Empowered Funds, LLC Laboratory Corp Of America Holdings Transaction History

Empowered Funds, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$209.01 - $232.56 $664,024 - $738,843	3,177 Added 248.98%	4,453 $972,000
Q3 2023 Nov 01, 2023	BUY	$201.05 - $221.7 $57,299 - $63,184	285 Added 28.76%	1,276 $256,000
Q2 2023 Jul 27, 2023	BUY	$211.93 - $241.33 $210,022 - $239,158	991 New	991 $239,000
Q2 2022 Aug 01, 2022	SELL	$213.86 - $277.87 $3.54 Million - $4.6 Million	-16,542 Closed	0 $0
Q1 2022 Apr 21, 2022	BUY	$259.82 - $298.18 $266,835 - $306,230	1,027 Added 6.62%	16,542 $4.36 Million
Q4 2021 Feb 10, 2022	BUY	$271.6 - $314.21 $221,354 - $256,081	815 Added 5.54%	15,515 $4.88 Million
Q3 2021 Nov 12, 2021	SELL	$274.82 - $308.34 $125,592 - $140,911	-457 Reduced 3.02%	14,700 $4.14 Million
Q2 2021 Aug 04, 2021	BUY	$251.87 - $278.14 $3.82 Million - $4.22 Million	15,157 New	15,157 $4.18 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Empowered Funds, LLC, based on Form 13F filings with the SEC.

Stay updated on Empowered Funds, LLC with notifications on news.